Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 3.47%.

  • MDxHealth's EBITDA Margin rose 200600.0% to 3.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year increase of 208500.0%. This contributed to the annual value of 13.0% for FY2024, which is 146200.0% up from last year.
  • MDxHealth's EBITDA Margin amounted to 3.47% in Q3 2025, which was up 200600.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's EBITDA Margin peaked at 239421.35% during Q3 2021, and registered a low of 287608.16% during Q2 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 16.59% (2024), whereas its average is 12082.91%.
  • In the last 5 years, MDxHealth's EBITDA Margin tumbled by 2000000000bps in 2022 and then skyrocketed by 2000000000bps in 2023.
  • MDxHealth's EBITDA Margin (Quarter) stood at 123.27% in 2021, then surged by 47bps to 181.48% in 2022, then plummeted by -112bps to 22.53% in 2023, then surged by 75bps to 5.57% in 2024, then skyrocketed by 162bps to 3.47% in 2025.
  • Its EBITDA Margin stands at 3.47% for Q3 2025, versus 0.0% for Q2 2025 and 5.48% for Q1 2025.